<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Polymyalgia Rheumatica (PMR) Management Algorithm – NICE CKS 2024</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.0/css/all.min.css">
    <style>
        :root {
            --blue: #2563eb;
            --purple: #7c3aed;
            --green: #16a34a;
            --orange: #ea580c;
            --red: #dc2626;
            --amber: #d97706;
            --gray: #1f2937;
        }
        body {
            margin: 0;
            font-family: system-ui, -apple-system, sans-serif;
            background: #f8fafc;
            color: #1f2937;
            line-height: 1.6;
        }
        .container {
            display: flex;
            min-height: 100vh;
        }
        /* Sticky Progress Sidebar */
        .sidebar {
            position: sticky;
            top: 0;
            width: 280px;
            height: 100vh;
            background: var(--gray);
            color: white;
            padding: 2rem 0;
            overflow-y: auto;
        }
        .sidebar h2 {
            padding: 0 1.5rem;
            font-size: 1.1rem;
            margin-bottom: 2rem;
            color: #e2e8f0;
        }
        .sidebar ul {
            list-style: none;
            padding: 0;
            margin: 0;
        }
        .sidebar li {
            margin: 0;
        }
        .sidebar a {
            display: block;
            padding: 1rem 1.5rem;
            color: #cbd5e1;
            text-decoration: none;
            transition: all 0.3s ease;
            border-left: 4px solid transparent;
        }
        .sidebar a:hover, .sidebar a.active {
            background: #334155;
            color: white;
            border-left-color: var(--blue);
        }
        .sidebar a.active {
            font-weight: 600;
            background: #1e293b;
        }

        /* Main Content */
        .main {
            flex: 1;
            padding: 2rem 3rem;
            max-width: 900px;
        }
        .card {
            background: white;
            border-radius: 12px;
            box-shadow: 0 10px 25px rgba(0,0,0,0.08);
            margin-bottom: 2.5rem;
            overflow: hidden;
            transition: all 0.4s ease;
        }
        .card:hover {
            transform: translateY(-8px);
            box-shadow: 0 20px 40px rgba(0,0,0,0.15);
        }
        .card-header {
            padding: 1.5rem 2rem;
            cursor: pointer;
            font-size: 1.4rem;
            font-weight: 700;
            display: flex;
            align-items: center;
            gap: 1rem;
            transition: background 0.3s;
        }
        .card-header i {
            font-size: 1.8rem;
        }
        #assessment .card-header { background: var(--blue); color: white; }
        #diagnosis .card-header { background: var(--purple); color: white; }
        #treatment .card-header { background: var(--green); color: white; }
        #followup .card-header { background: var(--orange); color: white; }

        .card-content {
            padding: 0 2rem 2rem;
            max-height: 5000px;
            opacity: 1;
            transition: all 0.6s ease;
        }
        .card.collapsed .card-content {
            max-height: 0;
            padding: 0 2rem;
            opacity: 0;
            overflow: hidden;
        }
        .badge {
            padding: 0.4rem 0.8rem;
            border-radius: 999px;
            font-size: 0.85rem;
            font-weight: 600;
            display: inline-block;
        }
        .badge.red { background: #fee2e2; color: var(--red); border: 1px solid var(--red); }
        .badge.amber { background: #fef3c7; color: var(--amber); border: 1px solid var(--amber); }
        .badge.green { background: #f0fdf4; color: var(--green); border: 1px solid var(--green); }

        .flow {
            background: #f1f5f9;
            padding: 1.5rem;
            border-radius: 8px;
            margin: 1.5rem 0;
            border-left: 5px solid var(--blue);
        }
        ul { padding-left: 1.4rem; }
        li { margin: 0.6rem 0; }
        .highlight { background: #fffbeb; padding: 1rem; border-radius: 8px; border: 1px solid #f59e0b; }

        @media (max-width: 992px) {
            .container { flex-direction: column; }
            .sidebar { position: relative; width: 100%; height: auto; padding: 1rem 0; }
            .main { padding: 1.5rem; }
        }
    </style>
</head>
<body>

<div class="container">
    <!-- Sticky Progress Sidebar -->
    <nav class="sidebar">
        <h2>PMR Algorithm (NICE CKS 2024)</h2>
        <ul>
            <li><a href="#assessment" class="active"><i class="fas fa-search"></i> Assessment</a></li>
            <li><a href="#diagnosis"><i class="fas fa-stethoscope"></i> Diagnosis</a></li>
            <li><a href="#treatment"><i class="fas fa-pills"></i> Treatment</a></li>
            <li><a href="#followup"><i class="fas fa-calendar-check"></i> Follow-up & Relapse</a></li>
        </ul>
    </nav>

    <div class="main">

        <!-- ASSESSMENT -->
        <section id="assessment" class="card">
            <div class="card-header">
                <i class="fas fa-search"></i> Assessment – When to Suspect PMR
            </div>
            <div class="card-content">
                <p><strong>Suspect PMR if age ≥50 AND ≥2 weeks of:</strong></p>
                <ul>
                    <li>Bilateral shoulder ± pelvic girdle aching (often worse with movement, disturbs sleep)</li>
                    <li>Morning stiffness ≥45 minutes (classic – difficulty rising, dressing, turning in bed)</li>
                </ul>
                <p><strong>Common additional features (40–70%):</strong></p>
                <ul>
                    <li>Constitutional: fatigue, low-grade fever, weight loss, anorexia</li>
                    <li>Bilateral upper arm tenderness</li>
                    <li>Peripheral arthritis (knees/wrists) or pitting oedema of hands/feet</li>
                </ul>

                <div class="flow">
                    <strong class="badge red">RED FLAG – SUSPECT GIANT CELL ARTERITIS (GCA)</strong><br><br>
                    <strong>Urgent same-day rheumatology / ophthalmology referral if ANY of:</strong>
                    <ul>
                        <li>New headache (especially temporal)</li>
                        <li>Scalp tenderness / temporal artery abnormality</li>
                        <li>Jaw claudication</li>
                        <li>Visual symptoms (amaurosis, diplopia, vision loss)</li>
                        <li>Limb claudication</li>
                    </ul>
                    <strong>→ Start prednisolone 40–60 mg immediately if GCA suspected</strong>
                </div>
            </div>
        </section>

        <!-- DIAGNOSIS -->
        <section id="diagnosis" class="card">
            <div class="card-header">
                <i class="fas fa-stethoscope"></i> Diagnosis
            </div>
            <div class="card-content">
                <div class="flow">
                    <strong>Core diagnostic requirements (age ≥50):</strong>
                    <ul>
                        <li>Bilateral shoulder ± pelvic girdle pain</li>
                        <li>Morning stiffness ≥45 min</li>
                        <li>Rapid response to prednisolone (≥70% improvement within 7 days)</li>
                        <li>Raised ESR/CRP (normal possible in 1–20%)</li>
                    </ul>
                </div>

                <p><strong>Investigations before starting steroids:</strong></p>
                <ul>
                    <li>ESR / PV and/or CRP (usually >40 mm/hr)</li>
                    <li>FBC, U&E, LFT, bone profile, TSH, CK</li>
                    <li>Rheumatoid factor, ACPA (if suspicion of RA)</li>
                    <li>Protein electrophoresis ± urine BJP (exclude myeloma)</li>
                    <li>Consider chest X-ray</li>
                </ul>

                <p><strong>Trial of prednisolone 15 mg daily</strong></p>
                <ul>
                    <li>Review at 1 week: ≥70% global improvement → highly likely PMR <span class="badge green">Confirmed PMR</span></li>
                    <li>Partial response → increase to 20 mg and reassess</li>
                    <li>Poor response or atypical features → reconsider diagnosis / refer <span class="badge amber">Consider early referral</span></li>
                </ul>

                <div class="highlight">
                    <strong>Atypical features → early rheumatology referral:</strong>
                    <ul>
                        <li>Age <60</li>
                        <li>Chronic onset (>2 months)</li>
                        <li>Normal or very high ESR/CRP (>100)</li>
                        <li>Predominant peripheral arthritis or distal swelling</li>
                        <li>Poor or transient response to steroids</li>
                        <li>Red flags (weight loss, night pain, neurological signs)</li>
                    </ul>
                </div>
            </div>
        </section>

        <!-- TREATMENT -->
        <section id="treatment" class="card">
            <div class="card-header">
                <i class="fas fa-pills"></i> Treatment
            </div>
            <div class="card-content">
                <p><strong>Initial treatment (confirmed PMR):</strong></p>
                <ul>
                    <li>Prednisolone <strong>15 mg once daily</strong> (12.5–20 mg range acceptable)</li>
                    <li>Continue 15 mg until symptoms controlled (usually 3–4 weeks)</li>
                    <li>Give steroid card + written information</li>
                    <li>Advise chickenpox/shingles avoidance</li>
                </ul>

                <div class="flow">
                    <strong>Suggested tapering schedule (adjust slower if relapse-prone):</strong>
                    <ul>
                        <li>Weeks 0–3–4: 15 mg</li>
                        <li>Weeks 4–7: 12.5 mg</li>
                        <li>Weeks 7–11: 10 mg</li>
                        <li>Then reduce by 1 mg every 4–8 weeks (or slower)</li>
                        <li>Typical duration 12–24 months (some lifelong low dose)</li>
                    </ul>
                </div>

                <p><strong>Bone protection (mandatory if ≥1 risk factor):</strong></p>
                <ul>
                    <li>Age ≥65 or previous fragility fracture → start bisphosphonate + calcium/vit D</li>
                    <li>Age <65 → calculate FRAX with steroid adjustment</li>
                </ul>

                <p><strong>Steroid-sparing agents:</strong> Consider methotrexate or tocilizumab early if high relapse risk or steroid side effects (specialist initiation).</p>
            </div>
        </section>

        <!-- FOLLOW-UP -->
        <section id="followup" class="card">
            <div class="card-header">
                <i class="fas fa-calendar-check"></i> Follow-up & Relapse Management
            </div>
            <div class="card-content">
                <p><strong>Monitoring schedule:</strong></p>
                <ul>
                    <li>1 week after any dose change</li>
                    <li>Every 3 months in first year</li>
                    <li>Check: symptoms of GCA, relapse, steroid side effects</li>
                    <li>Bloods: FBC, ESR/CRP, glucose, BP</li>
                </ul>

                <div class="flow">
                    <strong>Relapse (proximal pain + stiffness + ↑ESR/CRP):</strong>
                    <ul>
                        <li>Increase prednisolone to previous effective dose (usually 15–20 mg)</li>
                        <li>Symptoms usually settle within days</li>
                        <li>Once controlled → taper more slowly (e.g., 1 mg every 6–8 weeks below 10 mg)</li>
                    </ul>
                </div>

                <div class="highlight">
                    <strong>Refer to rheumatology if:</strong>
                    <ul>
                        <li>Cannot reduce below 10 mg after 6–12 months</li>
                        <li>Repeated relapses (≥2 per year)</li>
                        <li>Steroid side effects or high risk (diabetes, osteoporosis, etc.)</li>
                        <li>Diagnostic uncertainty</li>
                    </ul>
                </div>

                <p><strong>Patient support:</strong><br>
                PMRGCAuk (www.pmrgca.org.uk) – helpline 0300 111 5090, forums, information packs<br>
                Versus Arthritis – PMR booklet</p>
            </div>
        </section>

    </div>
</div>

<script>
    // Smooth scroll + active sidebar
    document.querySelectorAll('.sidebar a').forEach(link => {
        link.addEventListener('click', function(e) {
            e.preventDefault();
            const target = document.querySelector(this.getAttribute('href'));
            target.scrollIntoView({ behavior: 'smooth', block: 'start' });
        });
    });

    // Highlight active section in sidebar
    const sections = document.querySelectorAll('section[id]');
    const navLinks = document.querySelectorAll('.sidebar a');

    window.addEventListener('scroll', () => {
        let current = '';
        sections.forEach(section => {
            const rect = section.getBoundingClientRect();
            if (rect.top <= 100) {
                current = section.getAttribute('id');
            }
        });

        navLinks.forEach(link => {
            link.classList.remove('active');
            if (link.getAttribute('href') === `#${current}`) {
                link.classList.add('active');
            }
        });
    });

    // Expand/collapse cards
    document.querySelectorAll('.card-header').forEach(header => {
        header.addEventListener('click', () => {
            const card = header.parentElement;
            card.classList.toggle('collapsed');
        });
    });

    // Start with all cards expanded on desktop, collapsed on mobile
    if (window.innerWidth < 768) {
        document.querySelectorAll('.card').forEach(card => card.classList.add('collapsed'));
    }
</script>

</body>
</html>